Top 10 Companies in the Cellulose Acetate Phthalate (CAP) Enteric Coating for Drugs Market (2026): Market Leaders Driving Global Pharmaceutical Innovation

MARKET INSIGHTS

The Global Cellulose Acetate Phthalate (CAP) Enteric Coating for Drugs Market was valued at USD 0.32 billion in 2025 and is projected to rise to USD 0.58 billion by 2034, reflecting a CAGR of 6.9% over the forecast period. CAP, a pH‑sensitive polymer derived from cellulose, dissolves in the neutral to slightly alkaline milieu of the small intestine while remaining intact in the acidic stomach. This property allows it to shield acid‑labile active pharmaceutical ingredients (APIs) from gastric degradation and release them precisely in the intestine, thereby enhancing bioavailability and reducing gastrointestinal irritation.

Demand for CAP is sustained by the pharmaceutical industry’s push toward oral solid dosage forms that deliver drugs in a controlled, site‑specific manner. The prevalence of gastrointestinal disorders and the expansion of generic drug manufacturing further reinforce CAP’s position, as its proven film‑forming characteristics, broad API compatibility, and cost‑effective production make it an attractive choice for both immediate‑release and specialized delayed‑release products. Manufacturers are continuously refining polymer grades to satisfy stringent pharmacopeial standards and to meet the evolving needs of modern formulation science.

Cellulose Acetate Phthalate (CAP) Enteric Coating for Drugs Market – View in Detailed Research Report

Product Definition

Cellulose Acetate Phthalate is a semi‑synthetic cellulose derivative that functions as an enteric polymer. In tablet and capsule formulations, it creates a uniform, robust film that resists dissolution in gastric fluid but dissolves rapidly once the pH rises in the small intestine. This selective solubility ensures that the API remains protected until it reaches the intended site of absorption.

Top 10 Companies in the CAP Market

1️⃣ Eastman Chemical Company

Headquarters: Kingsport, Tennessee, USA
Key Offering: Eastman C‑A‑P enteric coating material, high‑purity NF/EP‑compliant grades engineered for tablet, capsule, and granule applications.

Eastman leads the global CAP market with a portfolio that satisfies the most rigorous regulatory frameworks. Its polymer grades exhibit exceptional film uniformity and rapid dissolution in intestinal pH, enabling formulators to achieve precise release profiles for acid‑sensitive APIs. The company invests heavily in process optimization, ensuring that CAP remains compatible with both solvent‑based and aqueous coating systems.

Sustainability Initiatives:

• Development of low‑solvent aqueous dispersions to reduce environmental impact.
• Investment in advanced curing technologies that lower energy consumption.
• Commitment to maintaining a closed‑loop water recycling system in key production facilities.

2️⃣ G.M. Chemie Pvt. Ltd.

Headquarters: Mumbai, India
Key Offering: Pharmaceutical‑grade CAP for domestic and export markets, compliant with USP, BP, and EP monographs.

G.M. Chemie has carved a niche in the Indian market by delivering high‑purity CAP at competitive pricing. Its emphasis on GMP compliance and continuous quality monitoring has earned the trust of contract manufacturers and large pharmaceutical companies seeking reliable excipient sources.

Growth Initiatives:

• Expansion of production capacity to meet rising demand for generic formulations.
• Collaboration with local universities to explore novel polymer blends.
• Implementation of ISO 9001‑based quality management systems.

3️⃣ Deepak Cellulose Private Limited

Headquarters: New Delhi, India
Key Offering: Bulk CAP powder and ready‑to‑use dispersions tailored for tablet and capsule coatings.

Deepak Cellulose focuses on delivering cost‑effective CAP solutions without compromising on purity. Its streamlined supply chain enables rapid turnaround for time‑critical formulation projects.

Innovation Focus:

• Development of low‑viscosity aqueous dispersions to enhance coating efficiency.
• Research into hybrid blends with hydroxypropyl methylcellulose phthalate.
• Participation in industry consortia to standardize dissolution testing protocols.

4️⃣ C. Jivanlal & Company

Headquarters: Ahmedabad, India
Key Offering: Custom CAP formulations for specialized delayed‑release products.

C. Jivanlal & Company leverages its deep experience in polymer chemistry to provide formulators with tailored CAP grades that meet specific release kinetics requirements.

Strategic Moves:

• Establishment of a dedicated R&D wing for polymer modification.
• Partnerships with contract manufacturers to co‑develop novel excipient blends.
• Adoption of digital quality monitoring systems.

5️⃣ Hipax Ester Pvt. Ltd.

Headquarters: Bangalore, India
Key Offering: High‑purity CAP for tablet and capsule applications, with emphasis on low‑solvent processing.

Hipax Ester provides a portfolio of CAP grades that are compatible with both traditional solvent‑based and emerging aqueous coating processes, enabling formulators to choose the most efficient route.

Key Initiatives:

• Investment in solvent‑free coating technologies.
• Development of high‑solids content dispersions to reduce packaging volume.
• Engagement with regulatory bodies to streamline approval pathways.

6️⃣ Daicel Corporation

Headquarters: Tokyo, Japan
Key Offering: Premium CAP grades for pharmaceutical and nutraceutical applications, compliant with Japanese Pharmacopeia and global standards.

Daicel’s CAP products are recognized for their superior film‑forming properties and low moisture uptake, making them ideal for sensitive APIs that require stringent protection.

R&D Focus:

• Exploration of biodegradable polymer blends.
• Optimization of polymer crystallinity to enhance dissolution control.
• Collaboration with academic institutions on advanced coating technologies.

7️⃣ Celanese Corporation

Headquarters: Irving, Texas, USA
Key Offering: Commercial CAP solutions for tablet and capsule coatings, with a focus on high‑purity, NF‑compliant grades.

Celanese supplies a broad range of CAP grades that support both conventional and advanced coating processes, ensuring consistent performance across diverse API matrices.

Operational Highlights:

• Implementation of lean manufacturing principles to reduce waste.
• Continuous improvement of solvent recovery systems.
• Strong emphasis on supply chain resilience.

8️⃣ Tata Chemicals Ltd.

Headquarters: Mumbai, India
Key Offering: Bulk CAP powder for tablet and capsule coatings, with a focus on cost‑effectiveness and regulatory compliance.

Tata Chemicals has positioned itself as a reliable supplier of CAP for large‑volume generic manufacturers, offering robust quality assurance and rapid delivery.

Strategic Development:

• Expansion of production lines to accommodate high‑volume demand.
• Integration of advanced quality control analytics.
• Participation in industry forums to harmonize dissolution testing.

9️⃣ BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Specialty CAP grades for pharmaceutical and nutraceutical applications, with a focus on low‑viscosity aqueous dispersions.

BASF’s CAP portfolio supports formulators seeking high‑solids, low‑solvent solutions that maintain film integrity while reducing environmental footprint.

Innovation Pipeline:

• Development of polymer blends with enhanced mechanical strength.
• Research into biodegradable excipient alternatives.
• Collaboration with global contract manufacturers.

🔟 Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: High‑purity CAP for tablet and capsule coatings, compliant with European pharmacopeia and international standards.

Bayer’s CAP solutions are known for their stability under a wide range of storage conditions, making them suitable for global distribution.

Strategic Focus:

• Investments in process scalability for high‑volume production.
• Strengthening of quality assurance frameworks.
• Active participation in regulatory harmonization initiatives.

Download FREE Sample Report:
Cellulose Acetate Phthalate (CAP) Enteric Coating for Drugs Market – View in Detailed Research Report

Get Full Report:
Cellulose Acetate Phthalate (CAP) Enteric Coating for Drugs Market – View in Detailed Research Report

Outlook

From 2026 to 2034, the CAP market is expected to maintain a steady growth trajectory, driven by the increasing prevalence of chronic gastrointestinal conditions and the continued expansion of generic drug manufacturing. The shift toward aqueous coating systems, motivated by environmental and safety considerations, will likely accelerate CAP adoption, particularly in regions with stringent solvent regulations. Market participants are expected to focus on the development of high‑solids, low‑viscosity dispersions that reduce solvent usage while preserving film quality, thereby delivering cost savings and environmental benefits.

Future Trends

• Hybrid coating systems that combine CAP with other pH‑sensitive polymers to fine‑tune dissolution profiles for complex APIs.
• Advancements in microencapsulation and controlled‑release technologies that leverage CAP’s robust film properties.
• Increased emphasis on sustainability, with manufacturers targeting reduced solvent footprints and improved energy efficiency in coating processes.
• Greater collaboration between polymer suppliers and pharmaceutical developers to accelerate the approval of novel excipient blends.
• Expansion of CAP applications into nutraceuticals and biopharmaceuticals, driven by the demand for oral delivery of peptides and proteins.